Beximco   Report issue

For profit Phase 3
Founded: Dhaka Bangladesh (1972)
Status: Left NME R&D (2014)

Organization Overview

First Clinical Trial
2008
NCT00860470
First Marketed Drug
1991
hydroxyzine (vistaril)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Beximco Pharmaceuticals Ltd. | BEXIMCO PHARMS USA | BEXIMCO USA | Dr. Md. Alimur Reza